Dreger, Peter <br/><br/>
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.  [electronic resource] 

 -  Blood  Apr 2013 
 - 3284-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2012-11-469627  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Phosphoproteins--genetics<br/>RNA Splicing Factors<br/>Receptor, Notch1--genetics<br/>Ribonucleoprotein, U2 Small Nuclear--genetics<br/>Transplantation, Homologous--methods<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--genetics